SBPH Insider Trading Activity and SEC Form 4 Filings
SBPH insider trading summary
No open-market insider purchases or sales of F-star Therapeutics, Inc. (SBPH) have been reported on SEC Form 4 in the past 12 months.
Latest SBPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 20, 2020 | Radhakrishnan P. Iyer | Chief Scientific Officer | Sell | $833 (175 @ $4.76) |
| Nov 20, 2020 | Martin J Driscoll | President and CEO | Sell | $833 (175 @ $4.76) |
| Nov 20, 2020 | Lori Firmani | VP of Finance and Treasurer | Sell | $833 (175 @ $4.76) |
| Nov 20, 2020 | Garrett Winslow | General Counsel and Secretary | Sell | $833 (175 @ $4.76) |
| Dec 30, 2019 | Kurt M Eichler | Director | Sell | $51K (40,000 @ $1.26) |
| Nov 14, 2019 | Jonathan Freve | CFO & Treasurer | Buy | $15K (5,000 @ $3.04) |
| Nov 13, 2019 | Martin J Driscoll | President and CEO | Buy | $14K (5,000 @ $2.83) |
| Jun 28, 2019 | Scott Andrew Smith | Director | Buy | $49K (12,000 @ $4.09) |
| May 29, 2019 | Jonathan Freve | CFO & Treasurer | Buy | $27K (5,000 @ $5.40) |
| May 29, 2019 | Martin J Driscoll | President and CEO | Buy | $60K (10,000 @ $6.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.